Skip to content

Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease

Safety and Feasibility of Using Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus to Improve Cognitive Performance in Patients With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03204526
Enrollment
15
Registered
2017-07-02
Start date
2015-06-30
Completion date
2019-11-30
Last updated
2021-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, Parkinson Disease

Brief summary

Prospective trial of low frequency deep brain stimulation of the ventral subthalamic nucleus to improve cognitive performance in patients with advanced Parkinson's disease. All study participants have undergone DBS implantation surgery as part of their routine care for motor manifestations of Parkinson's disease. In this study, a temporary low frequency period of stimulation will be applied to determine its effects on cognition.

Detailed description

In this randomized cross-over pilot study, our primary aim was to determine the effect of theta (5 Hz), and gamma (130 Hz) frequency stimulation in the ventral STN on cognitive control in patients with PD. This study provides a first look at frequency dependent modulation of cognitive function and provides important insights into the utility of DBS for non-motor symptoms of PD and other neuropsychiatric disorders.

Interventions

DEVICEdeep brain stimulation

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Parkinson's disease, undergoing deep brain stimulation implantation as part of their routine management of motor symptoms.

Design outcomes

Primary

MeasureTime frameDescription
Mean Reaction Time for Computerized Color Naming Stroop Task2 daysThe Stroop Color and Word Test (SCWT) is a neuropsychological test extensively used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute, well-known as the Stroop Effect.
Mean Accuracy Rates Using Computerized Color Naming Stroop Task2 daysThe Stroop Color and Word Test (SCWT) is a neuropsychological test extensively used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute, well-known as the Stroop Effect.

Secondary

MeasureTime frameDescription
Number of Participants With Worsening Depression Using Beck's Depression Index2 daysQuestionnaire with numerical score indicating level of depression. Individual scale items are scored on a 4-point continuum (0=least, 3=most), with a total summed score range of 0-63. Higher scores indicate greater depressive severity.
Number of Participants Showing Motor Worsening Using the Unified Parkinson's Disease Rating Scale (UPDRS-III)2 daysThe UPDRS scale is a rating tool used to gauge the course of Parkinson's disease in patients and consists of the following five segments: 1) Mentation, Behavior, and Mood, 2) ADL, 3) Motor sections, 4) Modified Hoehn and Yahr Scale, and 5) Schwab and England ADL scale.

Countries

United States

Participant flow

Participants by arm

ArmCount
Low Frequency Stimulation (LFS)
Low-frequency deep brain stimulation of the subthalamic nucleus deep brain stimulation
15
Total15

Baseline characteristics

CharacteristicLow Frequency Stimulation (LFS)
Age, Continuous62.18 Year
STANDARD_DEVIATION 6.42
Disease Duration7.73 Year
STANDARD_DEVIATION 3.38
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 15
other
Total, other adverse events
0 / 15
serious
Total, serious adverse events
0 / 15

Outcome results

Primary

Mean Accuracy Rates Using Computerized Color Naming Stroop Task

The Stroop Color and Word Test (SCWT) is a neuropsychological test extensively used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute, well-known as the Stroop Effect.

Time frame: 2 days

ArmMeasureValue (MEAN)
Low Frequency Stimulation (LFS)Mean Accuracy Rates Using Computerized Color Naming Stroop Task4.61 percent correct response
Primary

Mean Reaction Time for Computerized Color Naming Stroop Task

The Stroop Color and Word Test (SCWT) is a neuropsychological test extensively used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute, well-known as the Stroop Effect.

Time frame: 2 days

ArmMeasureValue (MEAN)
Low Frequency Stimulation (LFS)Mean Reaction Time for Computerized Color Naming Stroop Task5.09 seconds
Secondary

Number of Participants Showing Motor Worsening Using the Unified Parkinson's Disease Rating Scale (UPDRS-III)

The UPDRS scale is a rating tool used to gauge the course of Parkinson's disease in patients and consists of the following five segments: 1) Mentation, Behavior, and Mood, 2) ADL, 3) Motor sections, 4) Modified Hoehn and Yahr Scale, and 5) Schwab and England ADL scale.

Time frame: 2 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Low Frequency Stimulation (LFS)Number of Participants Showing Motor Worsening Using the Unified Parkinson's Disease Rating Scale (UPDRS-III)0 Participants
Secondary

Number of Participants With Worsening Depression Using Beck's Depression Index

Questionnaire with numerical score indicating level of depression. Individual scale items are scored on a 4-point continuum (0=least, 3=most), with a total summed score range of 0-63. Higher scores indicate greater depressive severity.

Time frame: 2 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Low Frequency Stimulation (LFS)Number of Participants With Worsening Depression Using Beck's Depression Index0 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026